What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

Esperion Therapeutics ESPR Return on equity

Discontinued — last reported Q3 '20

Return on equity at other companies

AmgenAMGN

101.3%-4.4pp

Regeneron PharmaceuticalsREGN

14.5%-1.4pp

NewAmsterdam Pharma CompanyNAMS

-29.5%-1.8pp

Lexicon PharmaceuticalsLXRX

-16%-7.2pp

Eton Pharmaceuticals, Inc.ETON

-34.2%+0.9pp

Zevra Therapeutics, Inc.ZVRA

100.7%+60.3pp

Other financials

Income statement

See full

Revenue$80.1M+23.2%

Operating income-$6.6M+70.2%

Net income-$25.2M+37.7%

EPS (diluted)-$0.10+52.4%

Balance sheet

See full

Cash & equivalents$156.2M+36.2%

Total debt$155.2M+6.1%

Total equity-$307.9M+27.8%

Total assets$462.5M+42.7%

Cash flow

See full

Operating cash flow-$27.7M-22.5%

CapEx$189.0K—

Free cash flow-$27.9M-23.3%

Valuation

See full

Market cap$811.73M+283%

Enterprise value$810.81M+233%

P/S1.9×+1.1×

Profitability

See full

Operating margin18.1%+12.7pp

Net margin-34.8%+8.0pp

FCF margin-30.7%—

Returns & leverage

See full

Debt / equity0.8×—

Current ratio1.5×+0.4×

Where this comes from

Calculated from Esperion Therapeutics’s reported figures.

net income/total stockholders equity=-260.8%

Based on trailing twelve months.

The official record: Esperion Therapeutics’s 10-Q, filed November 2, 2021, on SEC EDGAR. View the filing →

Questions, answered.

What does return on equity mean?: Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.